{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:30:08Z","timestamp":1794047408455,"version":"4.8.0"},"reference-count":56,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"3","license":[{"start":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T00:00:00Z","timestamp":1651104000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"abstract":"<jats:p>Rarely, immunophenotypically immature B-cell precursor acute lymphoblastic leukemia (BCP-ALL) carries an immunoglobulin- MYC rearrangement (IG-MYC-r). This can result in diagnostic confusion with Burkitt lymphoma\/leukemia and use of individualized treatment schedules of unproven efficacy. Here we compare the molecular characteristics of these conditions and investigate historic clinical outcome data. We identified 90 cases registered in a national BCP-ALL clinical trial\/registry. When present, diagnostic material underwent cytogenetic, exome, methylome and transcriptome analyses. The outcomes analyzed were 3-year event-free survival and overall survival. IG-MYC-r was identified in diverse cytogenetic backgrounds, co-existing with either established BCP-ALL-specific abnormalities (high hyperdiploidy, n=3; KMT2A-rearrangement, n=6; iAMP21, n=1; BCR-ABL1, n=1); BCL2\/BCL6-rearrangements (n=15); or, most commonly, as the only defining feature (n=64). Within this final group, precursor-like V(D)J breakpoints predominated (8\/9) and KRAS mutations were common (5\/11). DNA methylation identified a cluster of V(D)J-rearranged cases, clearly distinct from Burkitt leukemia\/lymphoma. Children with IG-MYC-r within that subgroup had a 3-year event-free survival of 47% and overall survival of 60%, representing a high-risk BCP-ALL. To develop effective management strategies this group of patients must be allowed access to contemporary, minimal residual disease-adapted, prospective clinical trial protocols.<\/jats:p>","DOI":"10.3324\/haematol.2021.280557","type":"journal-article","created":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T02:57:49Z","timestamp":1651114669000},"page":"717-731","source":"Crossref","is-referenced-by-count":25,"title":["Molecular characterization and clinical outcome of B-cell precursor acute lymphoblastic leukemia with IG-MYC rearrangement"],"prefix":"10.3324","volume":"108","author":[{"given":"Simon","family":"Bomken","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Enshaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward C.","family":"Schwalbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aneta","family":"Mikulasova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfeng","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masood","family":"Zaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent T.M.","family":"Fung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Bashton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huezin","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nefeli","family":"Karataraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Winterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cody","family":"Ashby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andishe","family":"Attarbaschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Bertrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jutta","family":"Bradtke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Buldini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.A. Amos","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Cazzaniga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gudrun","family":"Gohring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hesta A.","family":"De Groot-Kruseman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Haferlach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca Lo","family":"Nigro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayur","family":"Parihar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Plesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Seaford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin","family":"Sonneveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Strehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent H.J.","family":"Van der Velden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikki","family":"Rand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen P.","family":"Hunger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine J.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris M.","family":"Bacon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik W.","family":"Van Delft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mignon L.","family":"Loh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Moppett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Vormoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian A.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony V.","family":"Moorman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa J.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2022,4,28]]},"reference":[{"key":"45295","doi-asserted-by":"crossref","unstructured":"Klapper W, Stoecklein H, Zeynalova S. Structural aberrations affecting the MYC locus indicate a poor prognosis independent of clinical risk factors in diffuse large B-cell lymphomas treated within randomized trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL). Leukemia. 2008; 22(12):2226-2229.","DOI":"10.1038\/leu.2008.230"},{"key":"45296","doi-asserted-by":"crossref","unstructured":"Savage KJ, Johnson NA, Ben-Neriah S. MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy. Blood. 2009; 114(17):3533-3537.","DOI":"10.1182\/blood-2009-05-220095"},{"key":"45297","doi-asserted-by":"crossref","unstructured":"Ott G, Rosenwald A, Campo E. Understanding MYC-driven aggressive B-cell lymphomas: pathogenesis and classification. Blood. 2013; 122(24):3884-3891.","DOI":"10.1182\/blood-2013-05-498329"},{"key":"45298","doi-asserted-by":"crossref","unstructured":"Mikulasova A, Ashby C, Tytarenko RG. Microhomology-mediated end joining drives complex rearrangements and overexpression of MYC and PVT1 in multiple myeloma. Haematologica. 2020; 105(4):1055-1066.","DOI":"10.3324\/haematol.2019.217927"},{"key":"45299","unstructured":"Swerdlow SH, Campo E, Harris NL. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (Revised 4th edition): International Agency for Research on Cancer (IARC). 2017."},{"key":"45300","doi-asserted-by":"crossref","unstructured":"Navid F, Mosijczuk AD, Head DR. Acute lymphoblastic leukemia with the (8;14)(q24;q32) translocation and FAB L3 morphology associated with a B-precursor immunophenotype: the Pediatric Oncology Group experience. Leukemia. 1999; 13(1):135-141.","DOI":"10.1038\/sj.leu.2401244"},{"key":"45301","doi-asserted-by":"crossref","unstructured":"Loh ML, Samson Y, Motte E. Translocation (2;8)(p12;q24) associated with a cryptic t(12;21)(p13;q22) TEL\/AML1 gene rearrangement in a child with acute lymphoblastic leukemia. Cancer Genet Cytogenet. 2000; 122(2):79-82.","DOI":"10.1016\/S0165-4608(00)00293-4"},{"key":"45302","doi-asserted-by":"crossref","unstructured":"Reid MM, Drewery C, Windebank KP. Surface immunoglobulin-negative acute lymphoblastic leukaemia with predominant L1 morphology, occasional L3 cells and t(8;22). Br J Haematol. 2003; 122(5):693.","DOI":"10.1046\/j.1365-2141.2003.04407.x"},{"key":"45303","doi-asserted-by":"crossref","unstructured":"Gupta AA, Grant R, Shago M, Abdelhaleem M. Occurrence of t(8;22)(q24.1;q11.2) involving the MYC locus in a case of pediatric acute lymphoblastic leukemia with a precursor B cell immunophenotype. J Pediatr Hematol Oncol. 2004; 26(8):532-534.","DOI":"10.1097\/01.mph.0000132736.31514.28"},{"key":"45304","doi-asserted-by":"crossref","unstructured":"Meeker ND, Cherry AM, Bangs CD, Kimble Frazer J. A pediatric B lineage leukemia with coincident MYC and MLL translocations. J Pediatr Hematol Oncol. 2011; 33(2):158-160.","DOI":"10.1097\/MPH.0b013e3181e65c39"},{"key":"45305","doi-asserted-by":"crossref","unstructured":"Roug AS, Wendtland P, Bendix K, Kjeldsen E. Supernumerary isochromosome 1, idic(1)(p12), leading to tetrasomy 1q in Burkitt lymphoma. Cytogenet Genome Res. 2014; 142(1):7-13.","DOI":"10.1159\/000355985"},{"key":"45306","doi-asserted-by":"crossref","unstructured":"Sato Y, Kurosawa H, Fukushima K, Okuya M, Arisaka O. Burkitt-type acute lymphoblastic leukemia with precursor B-cell Immunophenotype and partial tetrasomy of 1q: a case report. Medicine (Baltimore). 2016; 95(10):e2904.","DOI":"10.1097\/MD.0000000000002904"},{"key":"45307","doi-asserted-by":"crossref","unstructured":"Meznarich J, Miles R, Paxton CN, Afify Z. Pediatric B-cell lymphoma with lymphoblastic morphology, TdT expression, MYC rearrangement, and features overlapping with Burkitt lymphoma. Pediatr Blood Cancer. 2016; 63(5):938-940.","DOI":"10.1002\/pbc.25907"},{"key":"45308","doi-asserted-by":"crossref","unstructured":"Gu Z, Churchman ML, Roberts KG. PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia. Nat Genet. 2019; 51(2):296-307.","DOI":"10.1038\/s41588-018-0315-5"},{"key":"45309","doi-asserted-by":"crossref","unstructured":"Forestier E, Johansson B, Borgstr\u00f6m G, Kerndrup G, Johansson J, Heim S. Cytogenetic findings in a population-based series of 787 childhood acute lymphoblastic leukemias from the Nordic countries. The NOPHO Leukemia Cytogenetic Study Group. Eur J Haematol. 2000; 64(3):194-200.","DOI":"10.1034\/j.1600-0609.2000.90103.x"},{"key":"45310","doi-asserted-by":"crossref","unstructured":"Wagener R, Lopez C, Kleinheinz K. IG-MYC (+) neoplasms with precursor B-cell phenotype are molecularly distinct from Burkitt lymphomas. Blood. 2018; 132(21):2280-2285.","DOI":"10.1182\/blood-2018-03-842088"},{"key":"45311","doi-asserted-by":"crossref","unstructured":"Herbrueggen H, Mueller S, Rohde J. Treatment and outcome of IG-MYC(+) neoplasms with precursor B-cell phenotype in childhood and adolescence. Leukemia. 2020; 34(3):942-946.","DOI":"10.1038\/s41375-019-0606-6"},{"key":"45312","doi-asserted-by":"crossref","unstructured":"Zhang C, Amos Burke GAA. Pediatric precursor B-cell acute lymphoblastic leukemia with MYC 8q24 translocation - how to treat?. Leuk Lymphoma. 2018; 59(8):1807-1813.","DOI":"10.1080\/10428194.2017.1387914"},{"key":"45313","doi-asserted-by":"crossref","unstructured":"Schwab CJ, Chilton L, Morrison H. Genes commonly deleted in childhood B-cell precursor acute lymphoblastic leukemia: association with cytogenetics and clinical features. Haematologica. 2013; 98(7):1081-1088.","DOI":"10.3324\/haematol.2013.085175"},{"key":"45314","doi-asserted-by":"crossref","unstructured":"Chen X, Schulz-Trieglaff O, Shaw R. Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications. Bioinformatics. 2016; 32(8):1220-1222.","DOI":"10.1093\/bioinformatics\/btv710"},{"key":"45315","doi-asserted-by":"crossref","unstructured":"Li H, Durbin R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics. 2010; 26(5):589-595.","DOI":"10.1093\/bioinformatics\/btp698"},{"key":"45316","doi-asserted-by":"crossref","unstructured":"McKenna A, Hanna M, Banks E. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010; 20(9):1297-1303.","DOI":"10.1101\/gr.107524.110"},{"key":"45317","doi-asserted-by":"crossref","unstructured":"Cibulskis K, Lawrence MS, Carter SL. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013; 31(3):213-219.","DOI":"10.1038\/nbt.2514"},{"key":"45318","doi-asserted-by":"crossref","unstructured":"Sharma T, Schwalbe EC, Williamson D. Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of group 3 and group 4 subtypes. Acta Neuropathol. 2019; 138(2):309-326.","DOI":"10.1007\/s00401-019-02020-0"},{"key":"45319","doi-asserted-by":"crossref","unstructured":"Bray NL, Pimentel H, Melsted P, Pachter L. Near-optimal probabilistic RNA-seq quantification. Nat Biotechnol. 2016; 34(5):525-527.","DOI":"10.1038\/nbt.3519"},{"key":"45320","doi-asserted-by":"crossref","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014; 15(12):550.","DOI":"10.1186\/s13059-014-0550-8"},{"key":"45321","doi-asserted-by":"crossref","unstructured":"Lilljebjorn H, Henningsson R, Hyrenius-Wittsten A. Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia. Nat Commun. 2016; 7:11790.","DOI":"10.1038\/ncomms11790"},{"key":"45322","unstructured":"van der Maaten L, Hinton G. Visualising data using t-SNE. J Mach Learn Res. 2008; 9(86):2579-2605."},{"key":"45323","doi-asserted-by":"crossref","unstructured":"Newman AM, Zaka M, Zhou P. Genomic abnormalities of TP53 define distinct risk groups of paediatric B-cell non-Hodgkin lymphoma. Leukemia. 2022; 36(3):781-789.","DOI":"10.1038\/s41375-021-01444-6"},{"key":"45324","doi-asserted-by":"crossref","unstructured":"Schiffman JD, Lorimer PD, Rodic V. Genome wide copy number analysis of paediatric Burkitt lymphoma using formalin-fixed tissues reveals a subset with gain of chromosome 13q and corresponding miRNA over expression. Br J Haematol. 2011; 155(4):477-486.","DOI":"10.1111\/j.1365-2141.2011.08883.x"},{"key":"45325","doi-asserted-by":"crossref","unstructured":"Scholtysik R, Kreuz M, Klapper W. Detection of genomic aberrations in molecularly defined Burkitt's lymphoma by array-based, high resolution, single nucleotide polymorphism analysis. Haematologica. 2010; 95(12):2047-2055.","DOI":"10.3324\/haematol.2010.026831"},{"key":"45326","doi-asserted-by":"crossref","unstructured":"Havelange V, Pepermans X, Ameye G. Genetic differences between paediatric and adult Burkitt lymphomas. Br J Haematol. 2016; 173(1):137-144.","DOI":"10.1111\/bjh.13925"},{"key":"45327","doi-asserted-by":"crossref","unstructured":"Moorman AV, Ensor HM, Richards SM. Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97\/99 randomised trial. Lancet Oncol. 2010; 11(5):429-438.","DOI":"10.1016\/S1470-2045(10)70066-8"},{"key":"45328","doi-asserted-by":"crossref","unstructured":"Yasuda T, Tsuzuki S, Kawazu M. Recurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults. Nat Genet. 2016; 48(5):569-574.","DOI":"10.1038\/ng.3535"},{"key":"45329","doi-asserted-by":"crossref","unstructured":"Liu YF, Wang BY, Zhang WN. Genomic profiling of adult and pediatric B-cell acute lymphoblastic leukemia. EBioMedicine. 2016; 8:173-183.","DOI":"10.1016\/j.ebiom.2016.04.038"},{"key":"45330","doi-asserted-by":"crossref","unstructured":"Zhang J, McCastlain K, Yoshihara H. Deregulation of DUX4 and ERG in acute lymphoblastic leukemia. Nat Genet. 2016; 48(12):1481-1489.","DOI":"10.1038\/ng.3691"},{"key":"45331","doi-asserted-by":"crossref","unstructured":"Love C, Sun Z, Jima D. The genetic landscape of mutations in Burkitt lymphoma. Nat Genet. 2012; 44(12):1321-1325.","DOI":"10.1038\/ng.2468"},{"key":"45332","doi-asserted-by":"crossref","unstructured":"Schmitz R, Young RM, Ceribelli M. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature. 2012; 490(7418):116-120.","DOI":"10.1038\/nature11378"},{"key":"45333","doi-asserted-by":"crossref","unstructured":"Richter J, Schlesner M, Hoffmann S. Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing. Nat Genet. 2012; 44(12):1316-1320.","DOI":"10.1038\/ng.2469"},{"key":"45334","doi-asserted-by":"crossref","unstructured":"Bouska A, Bi C, Lone W. Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets. Blood. 2017; 130(16):1819-1831.","DOI":"10.1182\/blood-2017-02-767335"},{"key":"45335","doi-asserted-by":"crossref","unstructured":"Nordlund J, B\u00e4cklin CL, Wahlberg P. Genome-wide signatures of differential DNA methylation in pediatric acute lymphoblastic leukemia. Genome Biol. 2013; 14(9):r105.","DOI":"10.1186\/gb-2013-14-9-r105"},{"key":"45336","doi-asserted-by":"crossref","unstructured":"Gabriel AS, Lafta FM, Schwalbe EC. Epigenetic landscape correlates with genetic subtype but does not predict outcome in childhood acute lymphoblastic leukemia. Epigenetics. 2015; 10(8):717-726.","DOI":"10.1080\/15592294.2015.1061174"},{"key":"45337","doi-asserted-by":"crossref","unstructured":"Bergmann AK, Castellano G, Alten J. DNA methylation profiling of pediatric B-cell lymphoblastic leukemia with KMT2A rearrangement identifies hypomethylation at enhancer sites. Pediatr Blood Cancer. 2017; 64(3):e26251.","DOI":"10.1002\/pbc.26251"},{"key":"45338","doi-asserted-by":"crossref","unstructured":"Hernandez-Vargas H, Gruffat H, Cros MP. Viral driven epigenetic events alter the expression of cancer-related genes in Epstein-Barr-virus naturally infected Burkitt lymphoma cell lines. Sci Rep. 2017; 7(1):5852.","DOI":"10.1038\/s41598-017-05713-2"},{"key":"45339","doi-asserted-by":"crossref","unstructured":"Liu W, Hu S, Konopleva M. De novo MYC and BCL2 doublehit B-cell precursor acute lymphoblastic leukemia (BCP-ALL) in pediatric and young adult patients associated with poor prognosis. Pediatr Hematol Oncol. 2015; 32(8):535-547.","DOI":"10.3109\/08880018.2015.1087611"},{"key":"45340","doi-asserted-by":"crossref","unstructured":"Sakaguchi K, Imamura T, Ishimaru S. Nationwide study of pediatric B-cell precursor acute lymphoblastic leukemia with chromosome 8q24\/MYC rearrangement in Japan. Pediatr Blood Cancer. 2020; 67(7):e28341.","DOI":"10.1002\/pbc.28341"},{"key":"45341","doi-asserted-by":"crossref","unstructured":"Anderson JR, Wilson JF, Jenkin DT. Childhood non-Hodgkin's lymphoma. The results of a randomized therapeutic trial comparing a 4-drug regimen (COMP) with a 10-drug regimen (LSA2-L2). N Engl J Med. 1983; 308(10):559-565.","DOI":"10.1056\/NEJM198303103081003"},{"key":"45342","doi-asserted-by":"crossref","unstructured":"Moorman AV, Harrison CJ, Buck GAN. Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII\/Eastern Cooperative Oncology Group (ECOG) 2993 trial. Blood. 2007; 109(8):3189-3197.","DOI":"10.1182\/blood-2006-10-051912"},{"key":"45343","doi-asserted-by":"crossref","unstructured":"Grande BM, Gerhard DS, Jiang A. Genome-wide discovery of somatic coding and non-coding mutations in pediatric endemic and sporadic Burkitt lymphoma. Blood. 2019; 133(12):1313-1324.","DOI":"10.1182\/blood-2018-09-871418"},{"key":"45344","doi-asserted-by":"crossref","unstructured":"Gelmann EP, Psallidopoulos MC, Papas TS, Dalla Favera R. Identification of reciprocal translocation sites within the c-myc oncogene and immunoglobulin mu locus in a Burkitt lymphoma. Nature. 1983; 306(5945):799-803.","DOI":"10.1038\/306799a0"},{"key":"45345","doi-asserted-by":"crossref","unstructured":"Busch K, Keller T, Fuchs U. Identification of two distinct MYC breakpoint clusters and their association with various IGH breakpoint regions in the t(8;14) translocations in sporadic Burkitt-lymphoma. Leukemia. 2007; 21(8):1739-1751.","DOI":"10.1038\/sj.leu.2404753"},{"key":"45346","doi-asserted-by":"crossref","unstructured":"L\u00f3pez C, Kleinheinz K, Aukema SM. Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphoma. Nat Commun. 2019; 10(1):1459.","DOI":"10.1038\/s41467-019-08578-3"},{"key":"45347","doi-asserted-by":"crossref","unstructured":"Bendig S, Walter W, Meggendorfer M. Whole genome sequencing demonstrates substantial pathophysiological differences of MYC rearrangements in patients with plasma cell myeloma and B-cell lymphoma. Leuk Lymphoma. 2021; 62(14):3420-3429.","DOI":"10.1080\/10428194.2021.1964021"},{"key":"45348","doi-asserted-by":"crossref","unstructured":"Paietta E, Roberts KG, Wang V. Molecular classification improves risk assessment in adult BCR-ABL1-negative B-ALL. Blood. 2021; 138(11):948-958.","DOI":"10.1182\/blood.2020010144"},{"key":"45349","doi-asserted-by":"crossref","unstructured":"Oberley MJ, Raikar SS, Wertheim GB. Significance of minimal residual disease in pediatric mixed phenotype acute leukemia: a multicenter cohort study. Leukemia. 2020; 34(7):1741-1750.","DOI":"10.1038\/s41375-020-0741-0"},{"key":"45350","doi-asserted-by":"crossref","unstructured":"Orgel E, Alexander TB, Wood BL. Mixed-phenotype acute leukemia: a cohort and consensus research strategy from the Children's Oncology Group Acute Leukemia of Ambiguous Lineage Task Force. Cancer. 2020; 126(3):593-601.","DOI":"10.1002\/cncr.32552"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2021.280557\/74424","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2021.280557\/75372","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/10624\/74424","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:01:34Z","timestamp":1794045694000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2021.280557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,28]]},"references-count":56,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,3,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2021.280557","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4,28]]}}}